S. Matin, Hassan Ghobadi, E. Safarzadeh, Leila Torabi Marjin, Masoomeh Dadkhah
Introduction: Since December 2019, coronavirus disease 2019 (COVID-19) has rapidly expanded to cause a worldwide pandemic. Objectives: We aimed to report the clinical characteristics of infected patients at the first wave in northwest of Iran. Patients and Methods: In this study, the epidemiological, demographic, clinical, and laboratory data of 1152 confirmed patients with COVID-19 who were admitted to two main hospitals at the first outbreak in northwest of Iran were collected and analyzed. Results: The most common clinical manifestations at onset were cough (65.8%), dyspnea (40.2%), myalgia (37.8%), and fever (63.4%), loss of appetite (47%), chest pain (38.6%), and headache (49.4%). While the less common were agitation (17.3%), vomiting (22.2%), diarrhea (16.7%), and nausea (24.3%). Laboratory data indicated significant correlation between lymphocyte counts with the severity of the disease based on O2 saturation. Conclusion: Overall, assessment the clinical data of COVID-19 patients play a crucial role in understanding the outbreak of novel viral pneumonia, which helps to identify high risk individuals with COVID-19.
{"title":"Clinical characteristics of hospitalized patients with COVID-19: Results from multiple-center experience in Ardabil, Northwest of Iran","authors":"S. Matin, Hassan Ghobadi, E. Safarzadeh, Leila Torabi Marjin, Masoomeh Dadkhah","doi":"10.34172/jpd.2023.11192","DOIUrl":"https://doi.org/10.34172/jpd.2023.11192","url":null,"abstract":"Introduction: Since December 2019, coronavirus disease 2019 (COVID-19) has rapidly expanded to cause a worldwide pandemic. Objectives: We aimed to report the clinical characteristics of infected patients at the first wave in northwest of Iran. Patients and Methods: In this study, the epidemiological, demographic, clinical, and laboratory data of 1152 confirmed patients with COVID-19 who were admitted to two main hospitals at the first outbreak in northwest of Iran were collected and analyzed. Results: The most common clinical manifestations at onset were cough (65.8%), dyspnea (40.2%), myalgia (37.8%), and fever (63.4%), loss of appetite (47%), chest pain (38.6%), and headache (49.4%). While the less common were agitation (17.3%), vomiting (22.2%), diarrhea (16.7%), and nausea (24.3%). Laboratory data indicated significant correlation between lymphocyte counts with the severity of the disease based on O2 saturation. Conclusion: Overall, assessment the clinical data of COVID-19 patients play a crucial role in understanding the outbreak of novel viral pneumonia, which helps to identify high risk individuals with COVID-19.","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84234598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
COVID-19 is a newly emerging infectious disease which first described in December 2019 Wuhan, China. The disease rapidly spread through the world and after a short time of emerging, the World Health Organization (WHO) declared COVID-19 as a pandemic. Since, respiratory system is the main organ affected by COVID-19, the kidney could be involved as well. Given the importance of the kidney involvement in COVID-19, in this study we tried to evaluate and describe the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on kidney.
{"title":"An overview on acute kidney injury following COVID-19","authors":"Mohammad-Reza Hajian, M. Momenzadeh","doi":"10.34172/jpd.2023.11179","DOIUrl":"https://doi.org/10.34172/jpd.2023.11179","url":null,"abstract":"COVID-19 is a newly emerging infectious disease which first described in December 2019 Wuhan, China. The disease rapidly spread through the world and after a short time of emerging, the World Health Organization (WHO) declared COVID-19 as a pandemic. Since, respiratory system is the main organ affected by COVID-19, the kidney could be involved as well. Given the importance of the kidney involvement in COVID-19, in this study we tried to evaluate and describe the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on kidney.","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88012302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Negar Karevan, Saeed Mardani, Sara Karevan, H. Mardanparvar, Maryam Ghasemi, Mohammad-Seddigh Ghaffari
Introduction: The role of vitamin D in metabolism, bone-mineral regulation, and anti-oxidation effect has drawn researchers’ attention toward its exact role in hemodialysis. Objectives: In this study, the effect of uric acid level reduction on serum 25-hydroxy vitamin D levels in hemodialysis patients was assessed. Patients and Methods: This study is a triple-blind clinical trial conducted on 81 hemodialysis patients suffering from asymptomatic hyperuricemia. Serum uric acid levels were assessed at the start of the study. Then patients were divided randomly into two groups of intervention and control. The intervention group received 100 mg of allopurinol tablets daily for two months. The control group received placebo tablets for the same duration. At the end of the study, 25-hydroxyvitamin D and uric acid levels were assessed. Data were analyzed using SPSS software and chi-square, independent t test, Mann–Whitney U, and Spearman’s rank correlation tests. Results: In our study, two groups of control and intervention were similar in terms of patients’ demographic and hemodialysis characteristics. After the intervention, compared to the control group, the serum uric acid levels were significantly lower in the intervention group, while the level of 25-hydroxyvitamin D showed no significant difference between the two groups. Conclusion: In this study, no significant effect of uric acid lowering therapy with vitamin D elevation in hemodialysis patients was detected. Trial Registration: The trial protocol was approved by the Iranian Registry of Clinical Trials (identifier: IRCT2015041721803N1; https:// en.irct.ir/trial/18996, ethical code#IR.SKUMS.1395.231).
维生素D在代谢、骨矿物质调节和抗氧化中的作用引起了研究人员对其在血液透析中的确切作用的关注。目的:观察降低尿酸水平对血液透析患者血清25-羟基维生素D水平的影响。患者和方法:本研究是一项针对81例无症状高尿酸血症血液透析患者的三盲临床试验。在研究开始时评估血清尿酸水平。然后将患者随机分为干预组和对照组。干预组给予别嘌呤醇片100mg，每日服用2个月。对照组在相同的时间内服用安慰剂片。在研究结束时，评估了25-羟基维生素D和尿酸水平。数据分析采用SPSS软件、卡方检验、独立t检验、Mann-Whitney U检验和Spearman秩相关检验。结果:在我们的研究中，对照组和干预组在患者人口统计学和血液透析特征方面相似。干预后，与对照组相比，干预组血清尿酸水平明显降低，而25-羟基维生素D水平两组间无显著差异。结论:在本研究中，血液透析患者降尿酸加维生素D升高治疗无明显效果。试验注册:试验方案已获得伊朗临床试验注册中心批准(标识符:IRCT2015041721803N1;https:// en.irct。ir/trial/18996，道德准则# ir . skums .1395.231)。
{"title":"Evaluating the effects of uric acid level reduction on serum vitamin D level in hemodialysis patients","authors":"Negar Karevan, Saeed Mardani, Sara Karevan, H. Mardanparvar, Maryam Ghasemi, Mohammad-Seddigh Ghaffari","doi":"10.34172/jpd.2023.11194","DOIUrl":"https://doi.org/10.34172/jpd.2023.11194","url":null,"abstract":"Introduction: The role of vitamin D in metabolism, bone-mineral regulation, and anti-oxidation effect has drawn researchers’ attention toward its exact role in hemodialysis. Objectives: In this study, the effect of uric acid level reduction on serum 25-hydroxy vitamin D levels in hemodialysis patients was assessed. Patients and Methods: This study is a triple-blind clinical trial conducted on 81 hemodialysis patients suffering from asymptomatic hyperuricemia. Serum uric acid levels were assessed at the start of the study. Then patients were divided randomly into two groups of intervention and control. The intervention group received 100 mg of allopurinol tablets daily for two months. The control group received placebo tablets for the same duration. At the end of the study, 25-hydroxyvitamin D and uric acid levels were assessed. Data were analyzed using SPSS software and chi-square, independent t test, Mann–Whitney U, and Spearman’s rank correlation tests. Results: In our study, two groups of control and intervention were similar in terms of patients’ demographic and hemodialysis characteristics. After the intervention, compared to the control group, the serum uric acid levels were significantly lower in the intervention group, while the level of 25-hydroxyvitamin D showed no significant difference between the two groups. Conclusion: In this study, no significant effect of uric acid lowering therapy with vitamin D elevation in hemodialysis patients was detected. Trial Registration: The trial protocol was approved by the Iranian Registry of Clinical Trials (identifier: IRCT2015041721803N1; https:// en.irct.ir/trial/18996, ethical code#IR.SKUMS.1395.231).","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81154776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Dehghani, Narges Esmaeili, M. Khosravian, H. Nasri
Implication for health policy/practice/research/medical education Various studies suggest an increased possibility of malignancy in primary hyperparathyroidism compared to the normal individuals which leads to increase mortality and morbidity; since, the location of the tumors is different. Several studies showing that the association between primary hyperparathyroidism and malignancy is more general in nature than emerge of a specific tumor, an issue which needs more investigations..
{"title":"Possible cancer enhancement impact of parathyroid hormone excess","authors":"M. Dehghani, Narges Esmaeili, M. Khosravian, H. Nasri","doi":"10.34172/jpd.2023.11195","DOIUrl":"https://doi.org/10.34172/jpd.2023.11195","url":null,"abstract":"Implication for health policy/practice/research/medical education Various studies suggest an increased possibility of malignancy in primary hyperparathyroidism compared to the normal individuals which leads to increase mortality and morbidity; since, the location of the tumors is different. Several studies showing that the association between primary hyperparathyroidism and malignancy is more general in nature than emerge of a specific tumor, an issue which needs more investigations..","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"139 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75476517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S. Kalbasi, H. Mardanparvar, A. Tajik, Danial Khazaeian, Ali Neyriz, F. Farsad, S. Ahmadi
Introduction: Goiter is a common problem in the world; however, it is more prevalent in countries with iodine deficiency. Goiter has different etiologies while one of them is Hashimoto’s thyroiditis. Selenium is a trace element that has different important effects in the body. It has also some effects in the thyroid. Objectives: This study aimed to evaluate the effect of selenium intake on goiter size and the correlation with goiter type. Patients and Methods: In prospective observational study, 20 patients with Hashimoto’s goiter and 40 patients with non-Hashimoto’s goiter were evaluated for thyroid sizes. The nodule sizes were else evaluated. After the first evaluation, daily selenium supplement (200 mg) was prescribed for all patients for six months. After this time, the sizes of goiter and nodules were measured again. Results: Results showed that the size of both goiter lobes in both Hashimoto’s and non-Hashimoto’s groups was significantly reduced before and after selenium intake (P<0.001). The reduction rate in left lobe size in patients with Hashimoto’s goiter was 50.73% and in nonHashimoto’s goiter patients was 20.89% (P<0.001). The reduction rate in right lobe size in patients with Hashimoto’s goiter was 53.37% and in non-Hashimoto’s goiter was 20.46 (P<0.001). Conclusion: We conclude that administration of selenium is effective in reducing the size of the goiter.
{"title":"Goiter size changes as an indicator of response to treatment following selenium intake, and its correlation with goiter type","authors":"S. Kalbasi, H. Mardanparvar, A. Tajik, Danial Khazaeian, Ali Neyriz, F. Farsad, S. Ahmadi","doi":"10.34172/jpd.2023.11182","DOIUrl":"https://doi.org/10.34172/jpd.2023.11182","url":null,"abstract":"Introduction: Goiter is a common problem in the world; however, it is more prevalent in countries with iodine deficiency. Goiter has different etiologies while one of them is Hashimoto’s thyroiditis. Selenium is a trace element that has different important effects in the body. It has also some effects in the thyroid. Objectives: This study aimed to evaluate the effect of selenium intake on goiter size and the correlation with goiter type. Patients and Methods: In prospective observational study, 20 patients with Hashimoto’s goiter and 40 patients with non-Hashimoto’s goiter were evaluated for thyroid sizes. The nodule sizes were else evaluated. After the first evaluation, daily selenium supplement (200 mg) was prescribed for all patients for six months. After this time, the sizes of goiter and nodules were measured again. Results: Results showed that the size of both goiter lobes in both Hashimoto’s and non-Hashimoto’s groups was significantly reduced before and after selenium intake (P<0.001). The reduction rate in left lobe size in patients with Hashimoto’s goiter was 50.73% and in nonHashimoto’s goiter patients was 20.89% (P<0.001). The reduction rate in right lobe size in patients with Hashimoto’s goiter was 53.37% and in non-Hashimoto’s goiter was 20.46 (P<0.001). Conclusion: We conclude that administration of selenium is effective in reducing the size of the goiter.","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72761060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Implication for health policy/practice/research/medical education Mechanistic impact of vitamin D therapy in glomerulopathies consists of preservation of morphological integrity of slit diaphragm, which leads to restoration of tight junction proteins. Vitamin D also avoids the loss of nephrin component of the glomerular basement membrane.
{"title":"Glomerulonephritis and impact of vitamin D; a short look to the recent evidence","authors":"M. Dehghani, H. Nasri","doi":"10.34172/jpd.2023.11196","DOIUrl":"https://doi.org/10.34172/jpd.2023.11196","url":null,"abstract":"Implication for health policy/practice/research/medical education Mechanistic impact of vitamin D therapy in glomerulopathies consists of preservation of morphological integrity of slit diaphragm, which leads to restoration of tight junction proteins. Vitamin D also avoids the loss of nephrin component of the glomerular basement membrane.","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90284183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rakhshaneh Goodarzi, S. Saadat, Fatemeh Janbozorgi, Behnaz Darban
Introduction: One of the old treatment methods for unconjugated hyperbilirubinemia in neonates is blood exchange transfusion, which is expensive, possibly high-risk, and time-consuming. Today phototherapy as a novel method can be a good alternative. Objectives: This study aimed to evaluate the zinc level alternation after phototherapy in neonates with hyperbilirubinemia. Patients and Methods: A descriptive-analytical study was conducted on 85 infants with hyperbilirubinemia who underwent phototherapy referred to the pediatric hospital in Bandar- Abbas, Iran from 2017 to 2018. Healthy infants over two days with idiopathic jaundice with a gestational age greater than 34 weeks and only breast-feed were enrolled. Serum zinc levels were measured before and after phototherapy, and their changes were evaluated. Results: Out of 85 neonates, 42 (49.4%) were male and 43 (50.6%) were female with a mean gestational age of 37.83 ± 0.58 weeks and admission age of 4.15 ± 1.70 days. Zinc level before phototherapy was 84.98 ± 52.06 (μg/dL) and after phototherapy was 234.41 ± 280.98. The difference between serum zinc levels before and after the phototherapy was significant therefore, the zinc level significantly increased after the phototherapy. Conclusion: Results showed that phototherapy increases serum zinc levels, which can cause zinc toxicity. It is wise to measure serum zinc levels before and during phototherapy and seek the appropriate medical care.
{"title":"Zinc level alternation after phototherapy in neonates with hyperbilirubinemia","authors":"Rakhshaneh Goodarzi, S. Saadat, Fatemeh Janbozorgi, Behnaz Darban","doi":"10.34172/jpd.2023.11193","DOIUrl":"https://doi.org/10.34172/jpd.2023.11193","url":null,"abstract":"Introduction: One of the old treatment methods for unconjugated hyperbilirubinemia in neonates is blood exchange transfusion, which is expensive, possibly high-risk, and time-consuming. Today phototherapy as a novel method can be a good alternative. Objectives: This study aimed to evaluate the zinc level alternation after phototherapy in neonates with hyperbilirubinemia. Patients and Methods: A descriptive-analytical study was conducted on 85 infants with hyperbilirubinemia who underwent phototherapy referred to the pediatric hospital in Bandar- Abbas, Iran from 2017 to 2018. Healthy infants over two days with idiopathic jaundice with a gestational age greater than 34 weeks and only breast-feed were enrolled. Serum zinc levels were measured before and after phototherapy, and their changes were evaluated. Results: Out of 85 neonates, 42 (49.4%) were male and 43 (50.6%) were female with a mean gestational age of 37.83 ± 0.58 weeks and admission age of 4.15 ± 1.70 days. Zinc level before phototherapy was 84.98 ± 52.06 (μg/dL) and after phototherapy was 234.41 ± 280.98. The difference between serum zinc levels before and after the phototherapy was significant therefore, the zinc level significantly increased after the phototherapy. Conclusion: Results showed that phototherapy increases serum zinc levels, which can cause zinc toxicity. It is wise to measure serum zinc levels before and during phototherapy and seek the appropriate medical care.","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"74 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78848575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Implication for health policy/practice/research/medical education The non-thyroidal illness syndrome is characterized by low triiodothyronine in people with normal thyroid status, commonly occurring in seriously ill patients or individuals with malnutrition. Several studies showed people with severe COVID-19 had much lower free triiodothyronine levels than the patients who had less sever COVID-19. Therefore, free serum triiodothyronine may become a predictor of the severity of COVID-19 and an indicator for its management.
{"title":"Thyroid status and severity or mortality of COVID-19","authors":"A. Hassanzadeh Rad, Amirhossein Fakhre Yaseri","doi":"10.34172/jpd.2022.11187","DOIUrl":"https://doi.org/10.34172/jpd.2022.11187","url":null,"abstract":"Implication for health policy/practice/research/medical education The non-thyroidal illness syndrome is characterized by low triiodothyronine in people with normal thyroid status, commonly occurring in seriously ill patients or individuals with malnutrition. Several studies showed people with severe COVID-19 had much lower free triiodothyronine levels than the patients who had less sever COVID-19. Therefore, free serum triiodothyronine may become a predictor of the severity of COVID-19 and an indicator for its management.","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"50 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73376819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lithium is a trace element that has been commonly used in treating bipolar affective disorder for years. Lithium therapy causes renal failure, several endocrine and metabolic abnormalities, such nephrogenic diabetes insipidus, thyroid abnormalities, and hypercalcemia. Early detection of lithium-related hypercalcemia and primary hyperparathyroidism will ameliorate patients’ situations. Besides, regular serum calcium and parathormone assessment in individuals on lithium therapy is strongly recommended.
{"title":"Lithium therapy and parathyroid gland interaction","authors":"R. Tolouian, A. Baradaran","doi":"10.34172/jpd.2022.11178","DOIUrl":"https://doi.org/10.34172/jpd.2022.11178","url":null,"abstract":"Lithium is a trace element that has been commonly used in treating bipolar affective disorder for years. Lithium therapy causes renal failure, several endocrine and metabolic abnormalities, such nephrogenic diabetes insipidus, thyroid abnormalities, and hypercalcemia. Early detection of lithium-related hypercalcemia and primary hyperparathyroidism will ameliorate patients’ situations. Besides, regular serum calcium and parathormone assessment in individuals on lithium therapy is strongly recommended.","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73276015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Red cell distribution width is an easy method to assess of erythrocyte size alteration, which can be conducted for the diagnosis of various hematological disorders like anemia related to iron deficiency and bone marrow disease. This marker could be a prognostic predictor of severe cases of COVID-19 too.
{"title":"COVID-19 and red cell distribution width","authors":"A. Baradaran, Narges Esmaeili","doi":"10.34172/jpd.2022.11184","DOIUrl":"https://doi.org/10.34172/jpd.2022.11184","url":null,"abstract":"Red cell distribution width is an easy method to assess of erythrocyte size alteration, which can be conducted for the diagnosis of various hematological disorders like anemia related to iron deficiency and bone marrow disease. This marker could be a prognostic predictor of severe cases of COVID-19 too.","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74246986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：